Literature DB >> 15942576

Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma.

Amir A Ghaferi1, Grover M Hutchins.   

Abstract

BACKGROUND: Staged palliative surgical procedures have been an effective treatment of complex congenital heart defects. The Fontan procedure has been of particular benefit to infants with functional single-ventricle complexes but with the consequence of a sustained increase of right-sided venous pressure.
METHODS: We reviewed the clinical and pathologic features of 9 autopsied patients having undergone the Fontan procedure, with special attention given to their liver pathology.
RESULTS: The 9 patients died from a few hours to 18 years after the Fontan operation. Chronic passive congestion was seen in 7 patients, and 4 patients surviving 4 to 18 years also had cardiac cirrhosis. Hepatic adenoma in the setting of cardiac cirrhosis was found in a patient surviving for 9 years. One patient surviving for 18 years had hepatocellular carcinoma superimposed on cardiac cirrhosis. Rupture of the hepatoma in this case led to fatal hemorrhage.
CONCLUSION: The study shows that chronically increased hepatic venous pressure from the Fontan procedure might lead to chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma.

Entities:  

Mesh:

Year:  2005        PMID: 15942576     DOI: 10.1016/j.jtcvs.2004.10.005

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  69 in total

1.  Percutaneous liver biopsy in Fontan patients.

Authors:  Abhay Srinivasan; Anthony K Guzman; Elizabeth B Rand; Jack Rychik; David J Goldberg; Pierre A Russo; Anne Marie Cahill
Journal:  Pediatr Radiol       Date:  2018-11-30

2.  An Emphasis on Screening to Detect Liver Cirrhosis and Hepatocellular Carcinoma in Patients Having Undergone the Fontan Procedure in Early Childhood.

Authors:  Samragnyi Madala; Kira MacDougall; Abhishek Polavarapu; Dinesh Gurala; Vivek Gumaste; Gerard Morvillo
Journal:  Case Rep Gastroenterol       Date:  2020-11-23

3.  Pulmonary arterial hypertension: an unusual cause of portal hypertension.

Authors:  Enric Reverter; Susana Seijo; Jaime Bosch
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-06

4.  Serial evaluation of hepatic function profile after Fontan operation.

Authors:  R Kaulitz; P Haber; E Sturm; J Schäfer; M Hofbeck
Journal:  Herz       Date:  2013-05-08       Impact factor: 1.443

5.  Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.

Authors:  T Ackerman; A Geerts; H Van Vlierberghe; J De Backer; K François
Journal:  Pediatr Cardiol       Date:  2018-07-21       Impact factor: 1.655

6.  Risk factors and serological markers of liver cirrhosis after Fontan procedure.

Authors:  Mikiko Shimizu; Kenji Miyamoto; Yunosuke Nishihara; Gaku Izumi; Shuji Sakai; Kei Inai; Toshio Nishikawa; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2015-09-19       Impact factor: 2.037

7.  Transvenous hepatic biopsy in stable Fontan patients undergoing cardiac catheterization.

Authors:  William N Evans; Brody J Winn; Noel S Yumiaco; Alvaro Galindo; Abraham Rothman; Ruben J Acherman; Humberto Restrepo
Journal:  Pediatr Cardiol       Date:  2014-05-10       Impact factor: 1.655

8.  Effect of Fontan operation on liver stiffness in children with single ventricle physiology.

Authors:  Frank W DiPaola; Kurt R Schumacher; Caren S Goldberg; Joshua Friedland-Little; Aishwarya Parameswaran; Jonathan R Dillman
Journal:  Eur Radiol       Date:  2016-10-17       Impact factor: 5.315

9.  The Fontan pathway: What's down the road?

Authors:  Sachin Khambadkone
Journal:  Ann Pediatr Cardiol       Date:  2008-07

10.  Pleural effusions in children undergoing cardiac surgery.

Authors:  Sachin Talwar; Sandeep Agarwala; Chander Mohan Mittal; Shiv Kumar Choudhary; Balram Airan
Journal:  Ann Pediatr Cardiol       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.